MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease ; volume:10 ; number:1 ; day:13 ; month:2 ; year:2018 ; pages:1-12 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (13.2.2018), 1-12, 12.2018
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Urheber
-
Pohland, Maximilian
- Beteiligte Personen und Organisationen
-
Pellowska, Maren
Asseburg, Heike
Hagl, Stephanie
Reutzel, Martina
Joppe, Aljoscha
Berressem, Dirk
Eckert, Schamim H.
Wurglics, Mario
Schubert‐Zsilavecz, Manfred
Eckert, Gunter P.
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0342-6
- URN
-
urn:nbn:de:1111-201804057729
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pohland, Maximilian
- Pellowska, Maren
- Asseburg, Heike
- Hagl, Stephanie
- Reutzel, Martina
- Joppe, Aljoscha
- Berressem, Dirk
- Eckert, Schamim H.
- Wurglics, Mario
- Schubert‐Zsilavecz, Manfred
- Eckert, Gunter P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease
AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Mitochondrial alterations in different Alzheimers disease mouse models
Nitric oxide donors rescue metabolic and mitochondrial dysfunction in obese Alzheimer’s model
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer’s disease
Mitochondrial Alterations in Alzheimer’s Disease: Insight from the 5xFAD Mouse Model
Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction
Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease
MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease
AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Mitochondrial alterations in different Alzheimers disease mouse models
Nitric oxide donors rescue metabolic and mitochondrial dysfunction in obese Alzheimer’s model
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer’s disease
Mitochondrial Alterations in Alzheimer’s Disease: Insight from the 5xFAD Mouse Model
Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction
Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease
MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease
AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
Mitochondrial alterations in different Alzheimers disease mouse models
Nitric oxide donors rescue metabolic and mitochondrial dysfunction in obese Alzheimer’s model
Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer’s disease
Mitochondrial Alterations in Alzheimer’s Disease: Insight from the 5xFAD Mouse Model
Diastolic dysfunction in Alzheimer’s disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction